Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients

Clinical trial NCT06317805 · RECRUITING

Trial details

NCT number: NCT06317805
Sponsor: AOP Orphan Pharmaceuticals AG
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2023-12-06
Primary completion: 2027-06-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.